The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.
Morrish
P K
PK
MRC Cyclotron Unit, Hammersmith Hospital, London, United Kingdom.
Sawle
G V
GV
Brooks
D J
DJ
D000368:Aged; D000375:Aging / Q000502:physiology; D002421:Caudate Nucleus / Q000000981:diagnostic imaging; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives; D018450:Disease Progression; D006801:Humans; D008137:Longitudinal Studies; D008875:Middle Aged; D017072:Neostriatum / Q000000981:diagnostic imaging*; D010300:Parkinson Disease / Q000000981:diagnostic imaging*; D011699:Putamen / Q000000981:diagnostic imaging; D014055:Tomography, Emission-Computed
C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine